Model performance of efficacy was further assessed by applying the model derived from our self-report data in a sample of 642 people who had provided HealthKit EHR data but had not completed the GLP1 survey, and hence were not used in the construction of the model
The costs associated with medical weight loss can vary depending on several factors, including the type of program, location, and the treatments included
Glaeser, D
This should be accounted for in research designs that include oral glucose tolerance tests or mixed meal tolerance tests, as retatrutides pharmacodynamic effects will blunt the glycemic response independent of changes in fasting glucose or insulin sensitivity
Chen XM, Ji SF, Liu YH, et al
weight loss was still continuing 100% of participants on 8mg or 12mg achieved at least 5% weight loss (the threshold for health benefits) 83% on 12mg achieved 15% weight loss, which is considered exceptional How Retatrutide Compares to Other GLP-1 Medications Each additional receptor target correlates with greater weight loss